Anne Prener is Senior Vice President for the Haemostasis Research & Development Portfolio at Novo Nordisk A/S. She joined Novo Nordisk in 1992 and has since then held positions as Vice President in International Product Safety, Quality, Product Supply and Global Development.

Anne is an MD from Copenhagen University and holds a PhD in Epidemiology.

Before joining Novo Nordisk she worked in cancer research in the Danish Cancer Society and as a lecturer at Harvard University School of Public Health, Boston, USA.